 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 7 | 1/1 | 返回列表 |
| 查看: 2448 | 回復(fù): 6 | ||
| 【懸賞金幣】回答本帖問題，作者jarm190將贈(zèng)送您 1 個(gè)金幣 | ||
jarm190鐵蟲 (初入文壇)
|
[求助]
論文SCI收錄編號(hào)查詢 已有1人參與
|
|
|
評(píng)職稱需要，求大神幫查詢一下論文是否被SCI收錄，如果收錄請(qǐng)幫查詢收錄編號(hào)（或收錄證明信息）。謝謝 論文標(biāo)題：Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. 作者：He S, Hu XW, Wang D, Han LF, Zhang DC, Wei C. 期刊：Clin Res Hepatol Gastroenterol. 2016 Sep 17;40(4):405-417. doi: 10.1016/j.clinre.2016.02.001. |
回復(fù)此樓» 猜你喜歡
275求調(diào)劑
已經(jīng)有9人回復(fù)
-
083000學(xué)碩274求調(diào)劑
已經(jīng)有5人回復(fù)
-
【求調(diào)劑】085601材料工程專碩 | 總分272 |
已經(jīng)有5人回復(fù)
-
275求調(diào)劑
已經(jīng)有13人回復(fù)
-
0856，材料與化工321分求調(diào)劑
已經(jīng)有8人回復(fù)
-
085701環(huán)境工程，267求調(diào)劑
已經(jīng)有12人回復(fù)
-
320分，材料與化工專業(yè)，求調(diào)劑
已經(jīng)有7人回復(fù)
-
085701環(huán)境工程求調(diào)劑
已經(jīng)有8人回復(fù)
-
295材料工程專碩求調(diào)劑
已經(jīng)有5人回復(fù)
-
265求調(diào)劑
已經(jīng)有8人回復(fù)
LIYUANDONG
木蟲 (著名寫手)
- 應(yīng)助: 11 (小學(xué)生)
- 金幣: 4464.9
- 散金: 59
- 紅花: 8
- 帖子: 1313
- 在線: 458.4小時(shí)
- 蟲號(hào): 599187
- 注冊(cè): 2008-09-11
- 專業(yè): 色譜分析
2樓2019-05-09 10:07:10
jarm190
鐵蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 24
- 帖子: 5
- 在線: 53分鐘
- 蟲號(hào): 15056791
- 注冊(cè): 2019-05-09
- 性別: GG
- 專業(yè): 病原細(xì)菌、細(xì)菌感染與宿主
3樓2019-05-09 10:15:15
LIYUANDONG
木蟲 (著名寫手)
- 應(yīng)助: 11 (小學(xué)生)
- 金幣: 4464.9
- 散金: 59
- 紅花: 8
- 帖子: 1313
- 在線: 458.4小時(shí)
- 蟲號(hào): 599187
- 注冊(cè): 2008-09-11
- 專業(yè): 色譜分析
4樓2019-05-09 10:16:11
jarm190
鐵蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 24
- 帖子: 5
- 在線: 53分鐘
- 蟲號(hào): 15056791
- 注冊(cè): 2019-05-09
- 性別: GG
- 專業(yè): 病原細(xì)菌、細(xì)菌感染與宿主
5樓2019-05-09 10:30:35
lwg3
木蟲 (文壇精英)
- 應(yīng)助: 2 (幼兒園)
- 金幣: 6439.3
- 紅花: 6
- 帖子: 16186
- 在線: 5614.1小時(shí)
- 蟲號(hào): 946820
- 注冊(cè): 2010-01-22
- 專業(yè): 無機(jī)合成和制備化學(xué)
★ ★ ★ ★
jarm190(liouzhan654代發(fā)): 金幣+4, 感謝交流 2019-05-09 13:52:26
jarm190(liouzhan654代發(fā)): 金幣+4, 感謝交流 2019-05-09 13:52:26
|
Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis 作者:He, S (He, Song)[ 1 ] ; Hu, XW (Hu, Xiao-Wu)[ 1 ] ; Wang, D (Wang, Dong)[ 1 ] ; Han, LF (Han, Ling-Fei)[ 1 ] ; Zhang, DC (Zhang, De-Chun)[ 2 ] ; Wei, C (Wei, Cheng)[ 1 ] CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 卷: 40 期: 4 頁: 405-417 DOI: 10.1016/j.clinre.2016.02.001 出版年: SEP 2016 文獻(xiàn)類型:Review 查看期刊影響力 摘要 Due to the high morbidity, mortality and late detection of hepatocellular carcinoma (HCC), it becomes a major public health challenge. MicroRNAs (miRNAs) have been reported to be aberrantly expressed in patients with HCC and thus may serve as potential diagnostic biomarkers. The aim of this study was to systematically assess the diagnostic accuracy of miRNAs as biomarkers for diagnosing HCC through a meta-analysis. Our results indicated that serum miRNAs had a relatively high diagnostic value for HCC diagnosis; the combination of serum 0:fetoprotein (AFP) and miRNAs displayed a better diagnostic accuracy than using AFP or miRNAs alone; the combination of multiple miRNAs assay in serum had the highest diagnostic accuracy in HCC diagnosis based on the published data. In conclusion, our meta-analysis suggests that miRNAs, especially serum miRNAs, had a relatively high diagnostic value for HCC diagnosis, which can discriminate HCC from healthy subjects and those with chronic hepatitis and cirrhosis easily, and may serve as a novel, less-invasive screening tool. (C) 2016 Elsevier Masson SAS. All rights reserved. 關(guān)鍵詞 KeyWords Plus  OTENTIAL BIOMARKER; CANCER STATISTICS; CHRONIC HEPATITIS; PERFORMANCE; RISK作者信息 通訊作者地址: He, S (通訊作者) Maanshan Municipal Hosp Grp, Maanshan Ctr, Clin Lab, 45 Hubei Rd, Maanshan 243000, Peoples R China. 地址: [ 1 ] Maanshan Municipal Hosp Grp, Maanshan Ctr, Clin Lab, 45 Hubei Rd, Maanshan 243000, Peoples R China 顯示更多 [ 2 ] Chongqing Med Univ, Mol Med & Tumor Res Ctr, Chongqing 400016, Peoples R China 電子郵件地址:jarm190@163.com 基金資助致謝 基金資助機(jī)構(gòu) 授權(quán)號(hào) Maanshan Municipal Public Health Bureau 查看基金資助信息 出版商 ELSEVIER MASSON, CORPORATION OFFICE, 65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE 期刊信息 Impact Factor (影響因子): Journal Citation Reports 類別 / 分類 研究方向:Gastroenterology & Hepatology Web of Science 類別:Gastroenterology & Hepatology 文獻(xiàn)信息 語言:English 入藏號(hào): WOS:000388875200013 PubMed ID: 27016891 ISSN: 2210-7401 eISSN: 2210-741X 其他信息 IDS 號(hào): ED5EU Web of Science 核心合集中的 "引用的參考文獻(xiàn)": 44 Web of Science 核心合集中的 "被引頻次": 7 |
» 本帖已獲得的紅花（最新10朵）
jarm1906樓2019-05-09 10:35:22
jarm190
鐵蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 24
- 帖子: 5
- 在線: 53分鐘
- 蟲號(hào): 15056791
- 注冊(cè): 2019-05-09
- 性別: GG
- 專業(yè): 病原細(xì)菌、細(xì)菌感染與宿主
7樓2019-05-09 10:42:47
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 jarm190 的主題更新
| 7 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 070300化學(xué)求調(diào)劑 +4 | 起個(gè)名咋這么難 2026-03-27 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 085600材料與化工306 +10 | z1z2z3879 2026-03-21 | 11/550 |
|
|
|
[考研] 312求調(diào)劑 +9 | 上岸吧ZJY 2026-03-22 | 13/650 |
|
|
|
[考研] 材料求調(diào)劑 +5 | .m.. 2026-03-25 | 5/250 |
|
|
|
[考研]
材料學(xué)碩，求調(diào)劑
 6+5
|
糖葫蘆888ll 2026-03-22 | 10/500 |
|
|
|
[考研]
 一志愿武漢理工，總分321，英一數(shù)二，求老師收留。
+5
|
nnnnnnn5 2026-03-25 | 5/250 |
|
|
|
[考研] 342求調(diào)劑 +3 | 加油a李zs 2026-03-26 | 3/150 |
|
|
|
[考研] 0703化學(xué)求調(diào)劑 +3 | 丹青奶蓋 2026-03-26 | 5/250 |
|
|
|
[考研] 一志愿北京化工大學(xué)材料與化工（085600）296求調(diào)劑 +9 | 稻妻小編 2026-03-26 | 9/450 |
|
|
|
[考研] 297求調(diào)劑 +6 | 田洪有 2026-03-26 | 6/300 |
|
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-25 | 3/150 |
|
|
|
[考研] 【2026考研調(diào)劑】制藥工程 284分 求相關(guān)專業(yè)調(diào)劑名額 +4 | 袁奐奐 2026-03-25 | 8/400 |
|
|
|
[考研] 各位老師您好：本人初試372分 +5 | jj涌77 2026-03-25 | 6/300 |
|
|
|
[考研] 材料調(diào)劑 +3 | iwinso 2026-03-23 | 3/150 |
|
|
|
[考研] 344求調(diào)劑 +3 | desto 2026-03-24 | 3/150 |
|
|
|
[考研] 284求調(diào)劑 +3 | yanzhixue111 2026-03-23 | 6/300 |
|
|
|
[考研] 石河子大學(xué)（211、雙一流）碩博研究生長(zhǎng)期招生公告 +3 | 李子目 2026-03-22 | 3/150 |
|
|
|
[考研] 求調(diào)劑 +4 | 要好好無聊 2026-03-21 | 4/200 |
|
|
|
[考研] 材料 271求調(diào)劑 +5 | 展信悅_ 2026-03-21 | 5/250 |
|
|
|
[考研] 材料與化工（0856）304求 B區(qū) 調(diào)劑 +3 | 邱gl 2026-03-21 | 3/150 |
|